WIC
BIIB icon

Willis Investment Counsel’s Biogen BIIB Stock Holding History

Willis Investment Counsel’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,000
Closed -$240K – 117
2021
Q4 		$240K Hold
1,000
– – 0.01% 107
2021
Q3 		$283K Sell
1,000
-10
-1% -$3.28K 0.02% 105
2021
Q2 		$350K Buy
1,010
+10
+1% +$3.03K 0.02% 106
2021
Q1 		$280K Buy
+1,000
New +$270K 0.02% 111

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Willis Investment Counsel's BIIB Position: Q1 2022 in Review

Willis Investment Counsel sold out of Biogen (BIIB) in Q1 2022, closing a stake of 1,000 shares — an estimated $240K sold.

Willis Investment Counsel first reported a position in BIIB in Q1 2021 and held it in 4 quarters. The position peaked at $350K in Q2 2021. 952 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

  • Willis Investment Counsel reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
  • Willis Investment Counsel sold 1,000 Biogen shares in Q1 2022, an estimated $240K.
  • Willis Investment Counsel first reported a position in Biogen in Q1 2021 and held it in 4 quarters.
  • Willis Investment Counsel's Biogen position peaked at $350K in Q2 2021.
  • 952 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Willis Investment Counsel's 13F filing for Q1 2022, filed 16 May 2022.